| Literature DB >> 22741027 |
Robert Johansson1, Sigrid Ekbladh, Amanda Hebert, Malin Lindström, Sara Möller, Eleanor Petitt, Stephanie Poysti, Mattias Holmqvist Larsson, Andréas Rousseau, Per Carlbring, Pim Cuijpers, Gerhard Andersson.
Abstract
BACKGROUND AND AIMS: Psychodynamic psychotherapy (PDT) is an effective treatment for major depressive disorder (MDD), but not all clients with MDD can receive psychotherapy. Using the Internet to provide psychodynamic treatments is one way of improving access to psychological treatments for MDD. The aim of this randomised controlled trial was to investigate the efficacy of an Internet-based psychodynamic guided self-help treatment for MDD.Entities:
Mesh:
Year: 2012 PMID: 22741027 PMCID: PMC3362510 DOI: 10.1371/journal.pone.0038021
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Participant flow and reasons for exclusion.
Abbreviations: MADRS-S: Montgomery-Åsberg Depression Rating Scale-Self-rated version; M.I.N.I.: Mini-International Neuropsychiatric Interview; ITT: Intention-to-treat.
Demographic description of the participants at randomization.
| Psychodynamic treatment | Support treatment | Total | ||
| Gender | Female | 37 (80.4%) | 32 (69.6%) | 69 (75.0%) |
| Male | 9 (19.6%) | 14 (30.4%) | 23 (25.0%) | |
| Age | Mean (SD) | 45.5 (15.2) | 45.8 (12.8) | 45.6 (14.0) |
| Min-Max | 22–73 | 21–72 | 21–73 | |
| Marital status | Married or co-habiting | 31 (67.4%) | 29 (63.0%) | 60 (65.2%) |
| Other | 15 (32.6%) | 17 (37.0%) | 32 (34.8%) | |
| Educational level | College or university, at least 3 years | 29 (63.0%) | 33 (71.7%) | 62 (67.4%) |
| College or university, shorter than 3 years | 9 (19.6%) | 6 (13.0%) | 15 (16.3%) | |
| Other | 6 (13.0%) | 6 (13.0%) | 12 (13.0%) | |
| Employment status | Employed | 32 (69.6%) | 38 (82.6%) | 70 (76.1%) |
| Other | 14 (30.4%) | 8 (17.4%) | 22 (23.9%) | |
| Medication | Present | 10 (21.7%) | 13 (28.3%) | 23 (25.0%) |
| Prior experience | 17 (37.0%) | 9 (19.6%) | 26 (28.3%) | |
| No experience | 19 (41.3%) | 24 (52.2%) | 43 (46.7%) | |
| Psychological treatment | Prior experience | 29 (63.0%) | 25 (54.3%) | 54 (58.7%) |
| No experience | 17 (37.0%) | 21 (45.7%) | 38 (41.3%) | |
| Depression | In acute episode | 32 (69.6%) | 28 (60.9%) | 60 (65.2%) |
| In partial remission | 14 (30.4%) | 18 (39.1%) | 32 (34.8%) | |
| Comorbidity | Social anxiety disorder | 15 (32.6%) | 14 (30.4%) | 29 (31.5%) |
| Generalized anxiety disorder | 16 (34.8%) | 11 (23.9%) | 27 (29.3%) | |
| Panic disorder | 5 (10.9%) | 2 (4.3%) | 7 (7.6%) | |
| Obsessive compulsive disorder | 1 (2.2%) | 1 (2.2%) | 2 (2.2%) | |
| Post-traumatic stress disorder | 3 (6.5%) | 0 (0.0%) | 3 (3.3%) | |
| Any anxiety disorder | 26 (56.5%) | 23 (50.0%) | 49 (53.3%) |
Figure 2Description of the self-help modules in the psychodynamic treatment.
Means, SDs and effect sizes (Cohen's d) for measures of depression, anxiety and quality of life.
| Mean ( | Effect size. | |||||
| Outcome measure | Pre- treatment | Post-treatment | 10-month follow-up | Between-group, post- treatment | Within-group, pre-post- treatment | Within-group, pre - 10-month follow-up |
| BDI-II | ||||||
| Psychodynamic treatment | 26.54 (5.8) | 11.48 (7.8) | 10.38 (9.6) | 1.11 (0.67–1.56) | 2.18 (1.49–2.86) | 1.94 (1.41–2.47) |
| Structured support treatment | 26.33 (6.7) | 20.22 (7.8) | 0.84 (0.46–1.21) | |||
| MADRS-S | ||||||
| Psychodynamic treatment | 23.07 (4.6) | 12.50 (7.8) | 11.23 (9.1) | 0.86 (0.43–1.30) | 1.56 (1.09–2.04) | 1.52 (1.05–1.99) |
| Structured support treatment | 23.48 (5.1) | 18.61 (6.4) | 0.84 (0.44–1.25) | |||
| PHQ-9 | ||||||
| Psychodynamic treatment | 12.61 (4.1) | 6.24 (5.0) | 5.00 (5.4) | 0.95 (0.51–1.39) | 1.46 (0.90–2.02) | 1.64 (1.05–2.23) |
| Structured support treatment | 13.30 (4.3) | 10.87 (4.8) | 0.54 (0.21–0.86) | |||
| GAD-7 | ||||||
| Psychodynamic treatment | 8.65 (3.4) | 5.29 (4.0) | 4.10 (4.1) | 0.52 (0.09–0.94) | 0.97 (0.58–1.36) | 1.20 (0.71–1.69) |
| Structured support treatment | 8.50 (4.2) | 7.61 (4.9) | 0.2 (−0.14–0.53) | |||
| BAI | ||||||
| Psychodynamic treatment | 20.96 (9.5) | 12.00 (8.9) | 9.54 (10.0) | 0.15 (−0.27–0.57) | 0.97 (0.66–1.29) | 1.15 (0.74–1.55) |
| Structured support treatment | 19.39 (10.2) | 13.35 (8.8) | 0.63 (0.37–0.88) | |||
| QOLI | ||||||
| Psychodynamic treatment | 0.35 (1.5) | 1.18 (1.7) | 1.65 (2.0) | 0.59 (0.16–1.02) | 0.48 (0.22–0.75) | 0.69 (0.35–1.03) |
| Structured support treatment | −0.08 (1.3) | 0.23 (1.5) | 0.22 (−0.04–0.48) | |||
Abbreviations: BDI-II: Beck Depression Inventory-II; MADRS-S: Montgomery-Åsberg Depression Rating Scale-Self-rated version; PHQ-9: 9-item Patient Health Questionnaire Depression Scale; GAD-7: Patient Health Questionnaire Generalized Anxiety Disorder Scale; BAI: Beck Anxiety Inventory; QOLI: Quality of Life Inventory.
Figure 3Weekly change on the Beck Depression Inventory-II during treatment and Beck Depression Inventory-II scores at each assessment point.